Osaic Holdings’s Plus Therapeutics PSTV Stock Holding History

Osaic Holdings’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21	Hold	5	–	–	﹤0.01%	7721
2025 Q4	$67	Hold	5	–	–	﹤0.01%	7675
2025 Q3	$59	Hold	5	–	–	﹤0.01%	7779
2025 Q2	$45	Hold	5	–	–	﹤0.01%	7621
2025 Q1	$126	Hold	5	–	–	﹤0.01%	7213
2024 Q4	$152	Hold	5	–	–	﹤0.01%	7202
2024 Q3	$194	Hold	5	–	–	﹤0.01%	7182
2024 Q2	$195	Hold	5	–	–	﹤0.01%	7171
2024 Q1	$240	Hold	5	–	–	﹤0.01%	6947
2023 Q4	$232	Hold	5	–	–	﹤0.01%	7018
2023 Q3	$178	Hold	5	–	–	﹤0.01%	7170
2023 Q2	$268	Hold	5	–	–	﹤0.01%	7159
2023 Q1	$580	Hold	5	–	–	﹤0.01%	7096
2022 Q4	$1K	Hold	5	–	–	﹤0.01%	6926
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	7040
2022 Q2	$1K	Sell	5 -23	-82%	-$5.74K	﹤0.01%	7132
2022 Q1	$11K	Hold	28	–	–	﹤0.01%	6085
2021 Q4	$11K	Buy	28 +4	+17%	+$2.31K	﹤0.01%	6191
2021 Q3	$17K	Buy	24 +3	+14%	+$2.29K	﹤0.01%	5887
2021 Q2	$20K	Hold	21	–	–	﹤0.01%	5666
2021 Q1	$19K	Buy	21 +5	+31%	+$5.07K	﹤0.01%	5518
2020 Q4	$12K	Buy	16 +7	+78%	+$5.99K	﹤0.01%	5442
2020 Q3	$9K	Buy	+9	New	+$8.73K	﹤0.01%	5337
2020 Q2	–	Hold	0	–	–	–	6277
2020 Q1	–	Hold	0	–	–	–	6153

Other funds holding PSTV

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Osaic Holdings's PSTV Position: Q1 2026 in Review

Osaic Holdings held its Plus Therapeutics (PSTV) position steady in Q1 2026 at 5 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7721.

Osaic Holdings first reported a position in PSTV in Q3 2020 and has held it in 23 quarters since. The position peaked at $20K in Q2 2021. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

Osaic Holdings held 5 shares of Plus Therapeutics worth $21 as of Q1 2026.
Osaic Holdings left its Plus Therapeutics share count unchanged in Q1 2026.
Plus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7721 holding.
Osaic Holdings first reported a position in Plus Therapeutics in Q3 2020 and has held it in 23 quarters since.
Osaic Holdings's Plus Therapeutics position peaked at $20K in Q2 2021.
23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.